Latest TNF inhibitor Stories
Mucosal Healing and Maintenance of Remission Have High Influence in Gastroenterologists' Prescribing Decision for UC, According to Findings from Decision Resources Group BURLINGTON, Mass.,
DUBLIN, April 9, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/stldww/global_psoriasis) has announced the addition of the "Global
ResearchMoz.us include new market research report "PharmaPoint: Crohns Disease - China Drug Forecast and Market Analysis to 2022" to its huge collection of research reports.
NORTH CHICAGO, Ill., March 20, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the initiation of a pivotal Phase 3 clinical trial that will evaluate the use of HUMIRA® (adalimumab) as a treatment
Proceeds Bring Series B to CHF 44.9 Million ZURICH-SCHLIEREN, Switzerland, Feb.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.